Literature DB >> 26144350

Prospective, multicenter validation of a clinical risk score for left atrial arrhythmogenic substrate based on voltage analysis: DR-FLASH score.

Jedrzej Kosiuk1, Borislav Dinov2, Jelena Kornej2, Willem-Jan Acou3, Robert Schönbauer4, Lukas Fiedler4, Piotr Buchta5, Krzysztof Myrda5, Mariusz Gąsior5, Lech Poloński5, Simon Kircher2, Arash Arya2, Philipp Sommer2, Andreas Bollmann2, Gerhard Hindricks2, Sascha Rolf2.   

Abstract

BACKGROUND: Left atrial (LA) low-voltage areas (LVAs) are frequently observed in patients with atrial fibrillation (AF) and may predict AF recurrence after catheter ablation.
OBJECTIVE: The aim of this study was to develop and validate a clinical tool to identify LVAs that are associated with AF recurrence after pulmonary vein isolation (PVI).
METHODS: In a cohort of 238 patients, voltage maps were created during LA procedures. LVAs were defined as areas with electrogram amplitudes <0.5 mV. On the basis of regression analysis, predictors of LA substrate were identified. These parameters were used to establish a dedicated risk score (DR-FLASH score, based on diabetes mellitus, renal dysfunction, persistent form of AF, LA diameter >45 mm, age >65 years, female sex, and hypertension). This risk score was then prospectively validated in a multicenter cohort of 180 patients. The association of the score with long-term recurrence of atrial arrhythmias after circumferential PVI was tested in a retrospective cohort of 484 patients.
RESULTS: The DR-FLASH score effectively identified LVA substrate (C statistic = 0.801, P < .001). In the prospective multicenter validation cohort, the predictive value of the DR-FLASH score was confirmed (C statistic = 0.767, P < .001). The probability for the presence of LA substrate increased by a factor of 2.2 (95% confidence interval [CI] 1.6-2.9, P < .001) with each point scored. Furthermore, the risk of AF recurrence after PVI increased by a factor of 1.3 (95% CI 1.1-1.5, P < .001) with every additional point and was almost 2 times higher in patients with a DR-FLASH score >3 (odds ratio 1.7, 95% CI 1.1-2.8, P = .026).
CONCLUSION: The DR-FLASH score may be useful to identify patients who may require extensive substrate modification instead of PVI alone.
Copyright © 2015 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ablation; Atrial fibrillation; Fibrosis; Outcome; Score

Mesh:

Year:  2015        PMID: 26144350     DOI: 10.1016/j.hrthm.2015.07.003

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  35 in total

Review 1.  Clinical scores used for the prediction of negative events in patients undergoing catheter ablation for atrial fibrillation.

Authors:  Falco Kosich; Katja Schumacher; Tatjana Potpara; Gregory Y Lip; Gerhard Hindricks; Jelena Kornej
Journal:  Clin Cardiol       Date:  2019-01-14       Impact factor: 2.882

2.  Predictors of arrhythmia recurrence in patients with heart failure undergoing left atrial ablation for atrial fibrillation.

Authors:  George Bazoukis; Konstantinos P Letsas; Gary Tse; Katerina K Naka; Panagiotis Korantzopoulos; Evangelia Ntzani; Konstantinos Vlachos; Athanasios Saplaouras; Eirini Pagkalidou; Lampros K Michalis; Antonios Sideris; Michael Efremidis
Journal:  Clin Cardiol       Date:  2018-01-22       Impact factor: 2.882

3.  Development and Validation of a Novel Prognostic Model Predicting the Atrial Fibrillation Recurrence Risk for Persistent Atrial Fibrillation Patients Treated with Nifekalant During the First Radiofrequency Catheter Ablation.

Authors:  Youzheng Dong; Zhenyu Zhai; Bo Zhu; Shucai Xiao; Yang Chen; Anxue Hou; Pengtao Zou; Zirong Xia; Jianhua Yu; Juxiang Li
Journal:  Cardiovasc Drugs Ther       Date:  2022-06-22       Impact factor: 3.727

4.  The impact of height on recurrence after index catheter ablation of paroxysmal atrial fibrillation.

Authors:  Ching-Han Liu; Li-Wei Lo; Fa-Po Chung; Shih-Lin Chang; Yu-Feng Hu; Yenn-Jiang Lin; Shih-Chung Huang; Su-Ting Gan; Chin-Yu Lin; Tze-Fan Chao; Jo-Nan Liao; Ta-Chuan Tuan; Chih-Min Liu; Yang-Che Shiu; Cheng-I Wu; Ling Kuo; Jennifer Jeanne B Vicera; Isaiah Lugtu; Cheng-Hung Li; Yu-Cheng Hsieh; Yi-Jen Chen; Shih-Ann Chen
Journal:  J Interv Card Electrophysiol       Date:  2021-09-01       Impact factor: 1.759

5.  The predictive value of galectin-3 levels on left atrial low voltage areas assessed by high-density mapping in patients with paroxysmal atrial fibrillation.

Authors:  Gökhan Aksan; Ahmet Yanık; Osman Can Yontar; Faruk Boyacı; Melisa Uçar; Mustafa Kürşat Şahin; Korhan Soylu
Journal:  J Arrhythm       Date:  2022-04-01

6.  The pre-ablation triglyceride-glucose index predicts late recurrence of atrial fibrillation after radiofrequency ablation in non-diabetic adults.

Authors:  Qinghui Tang; Xiao-Gang Guo; Qi Sun; Jian Ma
Journal:  BMC Cardiovasc Disord       Date:  2022-05-14       Impact factor: 2.174

7.  European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population.

Authors:  Jens Cosedis Nielsen; Yenn-Jiang Lin; Marcio Jansen de Oliveira Figueiredo; Alireza Sepehri Shamloo; Alberto Alfie; Serge Boveda; Nikolaos Dagres; Dario Di Toro; Lee L Eckhardt; Kenneth Ellenbogen; Carina Hardy; Takanori Ikeda; Aparna Jaswal; Elizabeth Kaufman; Andrew Krahn; Kengo Kusano; Valentina Kutyifa; Han S Lim; Gregory Y H Lip; Santiago Nava-Townsend; Hui-Nam Pak; Gerardo Rodríguez Diez; William Sauer; Anil Saxena; Jesper Hastrup Svendsen; Diego Vanegas; Marmar Vaseghi; Arthur Wilde; T Jared Bunch; Alfred E Buxton; Gonzalo Calvimontes; Tze-Fan Chao; Lars Eckardt; Heidi Estner; Anne M Gillis; Rodrigo Isa; Josef Kautzner; Philippe Maury; Joshua D Moss; Gi-Byung Nam; Brian Olshansky; Luis Fernando Pava Molano; Mauricio Pimentel; Mukund Prabhu; Wendy S Tzou; Philipp Sommer; Janice Swampillai; Alejandro Vidal; Thomas Deneke; Gerhard Hindricks; Christophe Leclercq
Journal:  Europace       Date:  2020-08-01       Impact factor: 5.214

8.  High Brain Natriuretic Peptide Level Predicts The Prevalence Of Low-Voltage Areas And Poor Rhythm Outcome In Patients Undergoing Atrial Fibrillation Ablation.

Authors:  Yasuhiro Matsuda; Masaharu Masuda; Mitsutoshi Asai; Osamu Iida; Shin Okamoto; Takayuki Ishihara; Kiyonori Nanto; Takashi Kanda; Takuya Tsujimura; Shota Okuno; Yosuke Hata; Hiroyuki Uematsu; Toshiaki Mano
Journal:  J Atr Fibrillation       Date:  2020-10-31

9.  Extensive Left Atrial Low-Voltage Area During Initial Ablation is Associated with A Poor Clinical Outcome Even Following Multiple Procedures.

Authors:  Takashi Kanda; Masaharu Masuda; Mitsutoshi Asai; Osamu Iida; Shin Okamoto; Takayuki Ishihara; Kiyonori Nanto; Takuya Tsujimura; Yasuhiro Matsuda; Yosuke Hata; Hiroyuki Uematsu; Toshiaki Mano
Journal:  J Atr Fibrillation       Date:  2021-08-31

10.  Advanced glycation end products predict long-term outcome of catheter ablation in paroxysmal atrial fibrillation.

Authors:  Allan Bohm; Lubos Urban; Lubomira Tothova; Ljuba Bacharova; Peter Musil; Jan Kyselovic; Peter Michalek; Tomas Uher; Branislav Bezak; Peter Olejnik; Robert Hatala
Journal:  J Interv Card Electrophysiol       Date:  2021-03-10       Impact factor: 1.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.